What Is A Varicocele? What Causes Varicocele?

Varicocele occurs when the network of veins that leave the testis (pampiniform plexus) become elongated and enlarged. The valves within the pampiniform plexus when they work properly only allow the blood to flow away from the testicle - if there is something wrong with them, blood builds up. Approximately 15% of men have a varicocele. [...]

Immunizing Patients With Gastrointestinal Diseases

Patients who need immunizations are falling through the cracks. Are you hesitant to immunize your IBD patients? Medscape Gastroenterology

FDA Sets Rules for Vending Machine Calorie Info

WASHINGTON (MedPage Today) — Vending machines, chain restaurants, and convenience stores would all have to prominently display the calorie counts of their foods under two proposed rules released by the FDA Friday.

Lab Notes: Love Hurts, and Hunger Makes the Nose Grow Stronger

(MedPage Today) — Neurologically speaking, romantic rejection is very much like physical pain; starvation makes the olfactory system more sensitive; and the Fountain of Youth may be colored yellow.

FDA Raises Level of Coronary Artery Seal Recall

(MedPage Today) — The FDA has elevated the recall of a coronary artery bypass procedure seal system to Class I because a lack of adhesive could cause the product to fail, possibly resulting in serious injury or death.

HHS Issues Accountable Care Organization Rule

WASHINGTON (MedPage Today) — The federal government released its much-awaited proposed rule for accountable care organizations on Thursday, projecting that the collaborative model of caring for Medicare patients could save up to $960 million over the next three years.

FDA Raises Level of Coronary Artery Seal Recall

(MedPage Today) — The FDA has elevated the recall of a coronary artery bypass procedure seal system to Class I because a lack of adhesive could cause the product to fail, possibly resulting in serious injury or death.

Boehringer Ingelheim’s BI 201335 new data against HCV highlighted at EASL meeting

New data presented today at the International Liver CongressTM 2011, the 46th Annual Meeting of the European Association for the Study of the Liver, in Berlin, highlighted the efficacy of Boehringer Ingelheim’s once-daily oral protease inhibitor BI 201335, in both treatment-naïve and -experienced patients with chronic genotype-1 hepatitis C virus infection. Genotype-1 HCV is the [...]

Boehringer Ingelheim advances into Phase 3 clinical trial of BI 201335

Boehringer Ingelheim today announced a preview of the study designs for the pivotal Phase 3 clinical trials evaluating BI 201335, its investigational once-daily oral protease inhibitor, in both treatment-naive and -experienced patients with chronic genotype-1 hepatitis C virus, the most challenging genotype to treat.

Encouraging early data from HCV vaccine phase I trial presented at International Liver Congress

Early data from phase I trials of an HCV vaccine presented today at the International Liver CongressTM show encouraging results, with high immunogenicity and good safety profile.